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PK15 cellswasting syndrome, which is primarily caused by porcine circovirus type 2
(PCV2), is an emerging and important swine disease. We have recently shown that PCV2 induces nuclear
factor kappa B activation and its activation is required for active replication, but the other cellular factors
involved in PCV2 replication are not well deﬁned. The extracellular signal-regulated kinase (ERK) which
served as an important component of cellular signal transduction pathways has been shown to regulate
many viral infections. In this report, we show that PCV2 activates ERK1/2 in PCV2-infected PK15 cells
dependent on viral replication. The PCV2-induced ERK1/2 leads to phosphorylation of the ternary complex
factor Elk-1, which kinetically paralleled ERK1/2 activation. Inhibition of ERK activation with U0126, a speciﬁc
MEK1/2 inhibitor, signiﬁcantly reduced viral progeny release. Investigations into the mechanism of ERK1/2
regulation revealed that inhibition of ERK activation leads to decreased viral transcription and lower virus
protein expression. These data indicate that the ERK signaling pathway is involved in PCV2 infection and
beneﬁcial to PCV2 replication in the cultured cells.
© 2009 Elsevier Inc. All rights reserved.IntroductionPorcine circovirus (PCV) is classiﬁed in the genus Circovirus of
the family Circoviridae (Todd et al., 2005). Two genotypes of PCV
have been identiﬁed. PCV type 1 (PCV1), which was ﬁrst recognized
in 1974 as a contaminant of a continuous porcine kidney cell line
(PK15) (Tischer et al., 1982), is known to be non-pathogenic to pigs
(Allan et al., 1995). Infection with PCV type 2 (PCV2) has been
associated with postweaning multisystemic wasting syndrome
(PMWS) in young weaned pigs, which was ﬁrst recognized in
Canada in 1991 (Clark, 1997). Nowadays, this disease and related
PCV2-associated diseases are occurring in all swine-producing areas
of the world and have become increasingly serious threats to global
pig production (Allan et al., 1998; Allan and Ellis, 2000; Choi et al.,
2000; Edwards and Sands, 1994; Fenaux et al., 2000; Mankertz et al.,
2000; Onuki et al., 1999; Segalés and Domingo, 2002). Usually
PMWS appears in pigs aged 5 to 18 weeks, and affected pigs show
fever, wasting or unthriftiness, respiratory distress, enlarged lymph
nodes and, occasionally, jaundice and diarrhea (Darwich et al., 2004;
Harding, 1996; Segalés and Domingo, 2002). Mortality rates may
vary from 1 to 2% up to 30% in complicated cases when co-infections
with porcine reproductive and respiratory syndrome virus, porcinel rights reserved.parvovirus, or Mycoplasma hyopneumoniae. Other risk factors
described in the Madec principles have been developed to correlate
with PMWS (Rose et al., 2003). Microscopic lesions are characterized
by lymphocyte depletion of follicular and interfollicular areas
together with macrophage inﬁltration of lymphoid tissues in
PMWS-affected pigs. Several lines of ﬁeld and experimental
evidence have suggested that severely PMWS affected pigs may
develop immunosuppression (Segalés et al., 2004).
PCV genome is a closed circular, single-stranded DNA molecule of
about 1.7 kb. Two major open reading frames (ORFs) have been
recognized for PCV, ORF1, called rep gene, which encodes a protein of
35.7 kDa involved in virus replication (Mankertz et al., 1998), and
ORF2, called cap gene, which encodes the major immunogenic capsid
protein of 27.8 kDa (Cheung, 2003; Nawagitgul et al., 2000). In
addition, a third open reading frame (ORF3) coding for an apoptosis-
associated protein has been reported for PCV2 and it is involved in
viral pathogenesis in vitro and in vivo (Liu et al., 2005, 2006). A recent
report has shown that PCV2 induces nuclear factor kappa B (NF-κB)
activation in cultured cells, and further revealed the role of NF-κB
activation in viral replication and PCV2-mediated apoptotic change
(Wei et al., 2008). However, whether the other signaling pathways
may also contribute to PCV2 infection in the cultured cells is still
unclear.
The extracellular signal-regulated kinase (ERK) signaling pathway
is one of the three mitogen-activated protein kinase (MAPK) cascades
that play important roles in the regulation of cell proliferation and
Fig. 1. PCV2 infection activates ERK1/2 signaling pathway in cultured cells. (A) Whole
cell lysates from PK15 cells after infection with PCV2 strain BJW at a MOI of 1 TCID50.
PCV2-infected cells 24, 48, 72, and 96 h were harvested, whole cell lysates were
prepared and resolved by SDS-PAGE, transferred to nitrocellulose membranes, and
immunoblotted by using antibody speciﬁc for ERK2, phosphorylated ERK1/2, as well as
PCV2 viral capsid protein ORF2. The amounts of β-actin were also assessed to monitor
the equal loadings of protein extracts. (B) ERK1/2 activation induced by PCV2 infection
was quantitatively determined using FACS assay. PK15 cells were ﬁxed at the indicated
time points with 4% formaldehyde and incubated with normal or anti-phospho-speciﬁc
antibodies directed against ERK1/2 followed by HRP-conjugated IgG antibodies. Total
and phosphorylated ERK were each assayed in triplicate. Cell numbers were normalized
using crystal violet. These results are representative of three independent experiments.
Values are shown as the mean±SD from triplicate wells. p-, phospho-.
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Johnson, 1999; Roux and Blenis, 2004). The ERK activation is initiated
by receptor tyrosine kinases that signal through the small GTP-
binding protein Ras. Activation of Ras leads to phosphorylation of Raf
kinase and in turn phosphorylates MEK1/2 followed by activating
ERK1/2 via phosphorylation on tyrosine and threonine residues
(Rubinfeld and Seger, 2005). The activated ERK1/2 translocates into
the nucleus and phosphorylates numerous downstream substrates
such as transcription factors c-myc, Ets, Elk-1, and Egr-1, which
ultimately regulate gene expression (Luttrell, 2003). Therefore, the
ERK signaling pathway involves in a wide range of cellular functions
including cell proliferation, transformatiom, differentiation, and cell
survival and death (Sebolt-Leopold et al., 1999; Luttrell, 2003).
Research data have shown that many viruses such as human
cytomegalovirus (Johnson et al., 2001), human immunodeﬁciency
virus type 1 (Yang and Gabuzda, 1999), inﬂuenza virus (Pleschka et al.,
2001), herpes virus (Perkins et al., 2002), coxsackievirus B3 (Luo et al.,
2002), vaccinia virus (Andrade et al., 2004; de Magalhães et al., 2001),
respiratory syncytial virus (Kong et al., 2004), Borna disease virus
(Planz et al., 2001), and coronavirus (Cai et al., 2007) manipulate the
ERK signaling pathway to regulate viral replication and gene
expression. However, the role of the ERK signaling pathway during
PCV2 replication is not clear.
Here, we reported that the ERK signaling pathway was activated in
the cultured cells by PCV2 infection and found that activation of the
host cellular pathway is essential for efﬁcient PCV2 infection. Further
experiments revealed that inhibition of this pathway reduces viral
transcription, protein synthesis, and PCV2 viral progeny release. These
results illustrate a mechanism by which PCV2 manipulates the ERK
signaling pathway to facilitate its infection and replication during viral
infection.
Results
Activation of ERK during PCV2 replication
It was reported that ERK is phosphorylated during varieties of
virus replication. In order to assess whether PCV2 infection activated
ERK1/2, the phosphorylation status of ERK1/2 was monitored on PK15
cells at different time points after infection by Western blot analysis.
The PK15 cells were infected with PCV2 strain BJW at a MOI of 1
TCID50, and whole cell lysates were prepared at the indicated times
after virus infection. Inoculation of PBS into PK15 cells served as
mock-infected controls. As shown in Fig. 1A, infection with PCV2 led
to progressive accumulation of p-ERK1/2 signals over time, and the
maximal induction of ERK1/2 was seen at 72 h postinfection. The
increased levels of ERK1/2 phosphorylation were concurrent with
expression of viral capsid protein ORF2 in the infected cells, but not
due to the enhanced production of these molecules or the difference
in protein extracts loaded, as the protein levels of total amounts of
ERK2, as well as β-actin, in each sample were comparable.
To further determine activated ERK1/2 quantitatively in the
infected cells, we used a Fast Activated Cell-Based ELISA (FACE)
assay to investigate the levels of ability of ERK1/2 phosphorylation at
different time points after PCV2 infection. Consistent with the results
shown in Fig. 1A, there was a time-dependent increase in the ERK1/2
phosphorylation in the PCV2-infected cells at 72 h postinfection
which decreased thereafter (Fig. 1B). At 72 h after infection, the
activation of phosphorylated ERK1/2 showed approximately 3.1-fold
higher than that in the mock-infected cells. In the mock-infected cells,
the level of ERK1/2 phosphorylation fell to its basal level. In addition,
the levels of total ERK1/2 remain unchanged in the PCV2-infected
cells at various time points after infection when compared to that in
the mock-infected cells. Thus, these data indicate that PCV2 infection
induces the activation of the cellular signaling pathway mediated by
ERK1/2.PCV2 replication is required for ERK1/2 phosphorylation
To determine whether PCV2 replication was required for ERK1/2
phosphorylation, we used the FACE assay to examine ERK1/2
phosphorylation in the cultured cells when infected with a UV light-
irradiated virus sample. PK15 cells were infected an unirradiated or
irradiated virus samples for 72 h postinfection. As shown in Fig. 2, no
signiﬁcant increase in activation of phosphorylated ERK1/2 was
observed in the UV-irradiated PCV2-infected cells as compared to
that in the mock-infected cells. In contrast, the levels of ERK1/2
phosphorylation increased by 3.5-fold when infected with the
unirradiated PCV2 at 72 h postinfection. The levels of total ERK1/2
remain unchanged in the PCV2-infected cells when compared to that
Fig. 2. PCV2 replication is required for ERK phosphorylation. Monolayer PK15 cells were
infected with PCV2 strain BJWat a MOI of 1 TCID50. At 72 h postinfection, PCV2-infected
cells and UV-irradiated PCV2-infected cells were ﬁxed with 4% formaldehyde. The FACE
assay was performed using normal or anti-phospho-speciﬁc antibodies directed against
ERK followed by HRP-conjugated IgG antibodies. Total and phosphorylated ERK were
each assayed in triplicate. Cell numbers were normalized using crystal violet. These
results are representative of three independent experiments. Values are shown as the
mean±SD from triplicate wells.
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replication was required for ERK1/2 phosphorylation.
ERK activation leads to Elk-1 phosphorylation
To conﬁrm that phosphorylation of ERK1/2 following PCV2
infection truly activated its downstream substrate Elk-1, the phos-
phorylation of the transcription factor was measured in the infected
cells by Western blotting. No activation of Elk-1 was detected in the
mock-infected PK15 cells. Sustained ERK1/2 activation after PCV2
infection leads to prolonged phosphorylation of Elk-1 (Fig. 3A), with
kinetics that paralleled those observed for ERK1/2. Cells exposed to the
UV-irradiated virus sample failed to phosphorylate Elk-1 (Fig. 3B). In
addition, Elk-1 phosphorylation was speciﬁcally impaired by preincu-
bation with MEK1/2 inhibitor U0126 at 20 μM (Fig. 3B). The result
demonstrated that activation of ERK1/2 induced by PCV2 infection isFig. 3. Phosphorylated ERK activates downstream target Elk-1 signal. (A) PK15 cells
were mock-infected or infected with PCV2 strain BJWat a MOI of 1 TCID50. At 24, 48, 72,
and 96 h postinfection, whole cell lysates were harvested and resolved by SDS-PAGE,
transferred to nitrocellulose membranes, and immunoblotted with anti-phospho-Elk-1
antibody. (B) PK15 cells were infected in the absence or presence of U0126 (at 20 μM).
Cell lysates were harvested to examine Elk-1 phosphorylation. β-actin was probed as
the loading control. p-, phospho-.possibly through the activation of its downstream components such
as Elk-1.
ERK regulates PCV2 replication
To determine whether activated ERK plays any role in the
replication of PCV2, we examined the effect of the kinase on progeny
virus production in the PCV2-infected PK15 cells by blocking ERK
activation. We infected PK15 cells with PCV2 in the presence of the
inhibitor U0126 (5–20 μM) or control (DMSO), and determined the
viral concentration in the cell culture supernatant 72 h after infection.
The kinase inhibitor was also present during infection and in
subsequent incubation periods. The selected concentrations of the
kinase inhibitor were tested to show their effectiveness in inhibiting
virus-induced ERK1/2 activity by the FACS assay, which demonstrated
that activation of ERK1/2 reduced dose-dependently (data not shown).
Seventy-two hours postinfection supernatants were collected and
viral production was determined by the IFA method. The inhibitor
U0126 at 5 μM inhibited PCV2 production in the cultured cells by 29%,
comparedwith controls (Fig. 4). Treatmentwith the inhibitor U0126 at
10 μM and 20 μM reduced PCV2 growth by 73% and 92%, respectively.
As expected, the UV-irradiated PCV2 failed to grow comparable to
those seen in themock-infected cells (Fig. 4). The result suggested that
ERK signal regulates the replication of PCV2 in PK15 cells.
Inhibition of ERK activation blocks PCV2 replication at the early stage
of infection
To more speciﬁcally identify the stage of PCV2 infection that was
targeted by the inhibition of ERK activation, we quantiﬁed PCV2
production after applying the inhibitor U0126 at different time points
postinfection. The cells were incubated until 72 h postinfection, and
the supernatants were collected for virus production assay. As shown
in Fig. 5, addition of U0126 at the time of infection led to a 91%
inhibition in virus production as compared to the DMSO-treated
control. Treatment between 2 and 8 h postinfection resulted in
signiﬁcant reduction of virus production (73% to 28% reduction
compared to the DMSO-treated control). In contrast, no signiﬁcant
differences in viral production were observed when the inhibitor was
added at 12 or 24 h postinfection. The result indicates that inhibition
of PCV2 infectivity by the inhibitor indeed occurs at the early stage in
PCV2 infection.Fig. 4. Inhibition of ERK1/2 phosphorylation blocks PCV2 replication. Supernatants of
PCV2-infected PK15 cells 72 h after treatment with various concentrations of the
inhibitor U0126 as well as UV-irradiated PCV2-infected cell supernatants 72 h were
inoculated on monolayers of PK15 cells. Virus productions were assayed by the IFA
method under a ﬂuorescence microscopy. The values represented are the means of the
results for three independent experiments; error bars show the standard deviations.
Fig. 6. (A) Inhibition of ERK1/2 phosphorylation decreases protein synthesis in the
PCV2-infected PK15 cells. The PCV2-Infected PK15 cells 72 h in the presence of U0126
(20 μM) as well as UV-irradiated PCV2-infected cells 72 h were assayed for the amount
of PCV2 viral capsid expression by the IFA method. The amounts of PCV2 ORF2 protein
expression are shown as percentages of the PCV2-positive signals in PCV2 alone-
infected cells. (B) Inhibition of ERK1/2 phosphorylation decreases viral transcription in
the PCV2-infected PK15 cells. Total RNAs (1 μg) isolated from PCV2-infected cells 48 h
after treatmentwith the inhibitor U0126 at the indicated concentrationswere subjected
to a real-time RT-PCR analysis. The relative amount of ORF2 mRNA was normalized to
that of β-actin mRNA and is expressed as multiples of the normalized value for PCV2-
infected and treated cells or mock-infected cells (control) in the same sample. The data
shown are mean values±SD based on three independent experiments; error bars show
the standard deviations.
Fig. 5. Inhibition of ERK1/2 pathway reduces PCV2 infectivity at the early stage of
infection. U0126 (20 μM) was added to PCV2-infected PK15 cells at −1, 0, 2, 4, 8, 12, and
24 h postinfection. At 72 h postinfection, the supernatants were collected and
determined for virus production by the IFA method. Experiments were performed in
triplicate; the data shown are mean values±SD based on three independent
experiments; error bars represent the standard deviations.
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viral transcription
To help delineate the mechanism of ERK1/2 regulation of PCV2
infection, we examined the effect of ERK inhibition on viral protein
expression. PK15 cells were infected with PCV2 (MOI of 1) in the
presence or absence of U0126 (20 μM), and ORF2 protein expression
was monitored by a ﬂuorescence microscopy. The ORF2 protein
expression was signiﬁcantly reduced when cells were treated with
U0126, as demonstrated by the increased number of PCV2-positive
cells observed in DMSO-treated infected cells (Fig. 6A). No signiﬁcant
differences were seen in the ORF2 protein expression between DMSO-
treated infected cells and untreated infected cells (data not shown).
No ORF2 protein expression was detected in the UV-irradiated PCV2-
infected as well as mock-infected cells (Fig. 6A).
We then examined the effect of ERK1/2 inhibition on PCV2 viral
mRNA synthesis, the real-time RT-PCR analysis was performed with
RNA extracted from PK15 cells 48 h after treatment with U0126 at
20 μM. The amount of each viral mRNA was normalized to that of β-
actin mRNA in the same sample. The abundance of PCV2 mRNA was
signiﬁcantly decreased in the PCV2-infected cells with U0126
treatment (Fig. 6B). At the indicated time point, the amount of
PCV2-speciﬁc mRNA in U0126-treated cells was approximately 2.6%
that of untreated cells. In contrast, the mRNA was detected in the
DMSO-treated PCV2-infected cells as seen in that in the PCV2-aloned-
infected cells (data not shown). No viral mRNA accumulation was
detected in the UV-irradiated PCV2-infected as well as mock-infected
cells (Fig. 6B). The results indicate that inhibition of ERK1/2 activation
did have an inhibitory effect on viral protein synthesis and the
accumulation of viral-speciﬁc mRNA in the PCV2-infected cells.
Discussion
Infection with a variety of viruses lead to the perturbation of host
cell signaling pathways including ERK MAPK cascade, which can
affect cellular function and virus replication. In the present study, we
show that ERK1/2 MAPK pathway was activated during the course of
PCV2 infection in PK15 cells (Figs. 1A and B), and its activation was
required for viral replication (Fig. 2). Also, we show that PCV2
infection induced the transcription factor Elk-1, which is a down-
stream substrate of ERK1/2, with kinetics that paralleled those
observed for ERK1/2 (Fig. 3). PCV2 replication was inhibited with the
MEK1/2 U0126 (Fig. 4). U0126 inhibited viral replication by 28%when added up to 8 h postinfection (Fig. 5), but subsequent addition
had little effect, conﬁrming that ERK is important at early steps of the
viral cycle. In addition, PCV2 viral transcription (Fig. 6B) and virus
protein synthesis (Fig. 6A) were reduced in the presence of U0126.
Together, these data suggest that the ERK1/2 signaling pathway is
manipulated by PCV2 and that the pathway plays a beneﬁcial role in
PCV2 replication.
Activation of the ERK pathway seems to be an essential require-
ment to regulate signals associated with biological functions during
virus infections. Many viruses utilize the ERK pathway for maximal
viral replication. Activated ERK1/2 was reported to enhance the
infectivity of human immunodeﬁciency virus (HIV), whereas treat-
ment of cells with the MEK1/2 inhibitor signiﬁcantly inhibited HIV
infectivity (Yang and Gabuzda, 1998, 1999). ERK MAPK is required for
Visna virus replication and virus-induced neuropathology (Barber et al.,
2002). Treating cells with the MEK1/2 inhibitor also signiﬁcantly
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Borna disease virus (Planz et al., 2001), Coxsackievirus B3 (Luo et al.,
2002), human cytomegalovirus (Johnson et al., 2001), vaccinia virus
(Andrade et al., 2004), coronavirus (Cai et al., 2007), and astrovirus
(Moser and Schultz-Cherry, 2008). In the present study, we deter-
mined whether PCV2-induced ERK1/2 activation is involved in viral
replication by examining the effect of the inhibitor U0126 on PCV2
production and found that inhibition of ERK1/2 activation signiﬁcantly
reduced the production of progeny virus (Fig. 4). This shows that
optimal PCV2 replication requires the ERK1/2 activity, and raises the
possibility that PCV2 has acquired the ability to activate the kinase to
aid its replication. Therefore, our ﬁndings indicate that PCV2-induced
activation of ERK is truly involved in the replication of PCV2 in PK15
cells and add a new member to the growing list of viruses whose
replication is modulated by the ERK signaling pathway.
ERK1/2 regulation of viral replication can act at speciﬁc steps of
the replication cycle, such as attachment, entry, gene transcription,
protein expression, and assembly. Borna disease virus requires active
ERK for entry (Planz et al., 2001). HIV-1 depends on the activation of
MEK ERK pathway to deliver its genomes into the cultured cells (Liu
et al., 2002). Inhibition of ERK during coronavirus infection
speciﬁcally decreases genomic and sgRNA production but has no
effect on protein synthesis (Cai et al., 2007). ERK activates adenovirus
gene transactivators, modulating protein expression (Schümann and
Dobbelstein, 2006; Whalen et al., 1997), with little effect on RNA
levels (Schümann and Dobbelstein, 2006). Inhibition of MEK/ERK
pathway reduces Kaposi's sarcoma-associated herpesvirus infectivity
but has no effect on virus binding to the cell surface receptor
(Naranatt et al., 2003). Vaccinia virus-induced ERK activation was
signiﬁcantly blocked by inhibition of ERK, which was simultaneously
paralleled by both delayed viral early-gene expression and a decrease
in viral DNA synthesis (Andrade et al., 2004). Inhibition of ERK
activation mediated by astrovirus reduces all steps of the viral life
cycle, including early and late protein expression as well as
subgenomic and genomic RNA transcription (Moser and Schultz-
Cherry, 2008). The function of activated ERK during PCV2 infection
was investigated in the present study. Our data showed that
treatment of cells with U0126 suppressed virus propagation at the
step of viral RNA transcription as well as viral protein synthesis. PCV
replicates via rolling circle replication involving an intermediate
double-stranded replicative form of DNA, and the rep proteins nick
and join the nucleotide segments at the initiation and termination of
the replication cycle (Cheung, 2006; Steinfeldt et al., 2006). Thus, it
was not surprising that treatment of PCV2-infected cells with
inhibition of ERK reduced viral transcripts as well as protein
expression, because viral transcription and protein synthesis are
closely related in the replication of PCV2. However, a detailed
mechanistic understanding of the inhibition of ERK activation on
PCV2 replication requires the identiﬁcation of particular cellular
factors which are the components of the ERK signaling pathway.
In conclusion, we have shown that PCV2 infection induces the
activation of ERK and its involvement in Elk-1 activation in the
cultured cells and demonstrate that the activation of ERK is required
for efﬁcient PCV2 replication. Inhibition of ERK activation signiﬁcantly
reduces viral protein expression and viral RNA transcription. The role
of ERK activation in PCV2 replication will contribute important
information about the molecular mechanism of PCV2 infection.
Materials and methods
Virus and cells
The permanent PK15 cell line, which was free of PCV, was
maintained in minimal essential medium (MEM) supplemented
with 5% heat-inactivated fetal bovine serum (FBS), 5% L-glutamine,
100 U of penicillin G/ml, and 100 μl of streptomycin/ml at 37 °C in ahumidiﬁed 5% CO2 incubator. The PCV2 virus used in the study was
originally isolated from a kidney tissue sample of a pig with naturally
occurring PMWS (strain BJW) (Liu et al., 2005).
For PCV2 infection, PK15 cells seeded the day before were infected
with PCV2 strain BJW at a multiplicity of infection (MOI) of 1 TCID50.
Cells were additionally treated with 300 mM D-glucosamine at 24 h
after infection as described previously (Tischer et al., 1987).
Reagents and antibodies
U0126 was purchased from Calbiochem (La Jolla, Calif.). PK15 cells
were treated with either DMSO which is the solvent for U0126 or
various concentrations (5–20 μM) for 1 h prior to infection. After 1 h of
virus adsorption, the virus inoculum was removed and fresh basal
medium containing fresh inhibitor was added to the culture. The
cytotoxicity of the inhibitors on PK15 cells was determined by trypan
blue exclusion dye staining. It was noted that throughout all doses of
the inhibitor used in this study, cell viability assay showed no
detectable cell death in PK15 cells.
Rabbit antibodies against ERK2, β-actin, as well as phosphorylated
ERK1/2 (p-ERK1/2) were purchased from Santa Cruz Biotechnology
(Hercules, CA). Antibody speciﬁc for phosphorylated forms of Elk-1
(p-Elk-1) was obtained from Cell Signaling Technology. Horseradish
peroxidise (HRP)-linked secondary antibodies were purchased from
Sigma.
Fast activated cell-based ELISA (FACE)
FACE kit to monitor the levels of ERK1/2 MAPK activation was
obtained from Active Motif. Procedure was performed strictly
according to the manufacturer's instructions. Brieﬂy, PK15 cells were
seeded in 96-well plates 1 day prior to infection. After treatment
and/or infection, cells were ﬁxed with 4% formaldehyde in PBS. After
washing and blocking, cells were reacted overnight with an anti-
ERK1/2 or anti-phospho-ERK1/2 antibody. Following incubation with
a HRP-conjugated secondary antibody, colorimetric analysis was
performed. A450 was determined using a plate spectrophotometer.
Quantitative real-time RT-PCR
Total cell RNAs were prepared from PCV2-infected PK15 cell 48 h
after being treated with various concentrations of the inhibitor U0126
by using Trizol RNA extract reagent (Invitrogen). The following
primers were used: ORF2 (sense) (5′-ATCAAGCGAACCACAG-3′) and
ORF2 (antisense) (5′-GGTCATAGGTGAGGGGC-3′) for PCV2 ORF2 and
sense (5′-CACGCCATCCTGCGTCTGGA-3′) and antisense (5′-AGCACC-
GTGTTGGCGTAGAG) for β-actin. The RNA samples were incubated
with DNase I for 60 min at 37 °C to remove any contaminating viral
DNA. cDNAs were reverse transcribed from total RNAs by the use of
antisense primers and the First-Strand synthesis system (Avian
Myeloblastosis Virus Reverse Transcriptase kit; Roche). Quantitative
real-time PCR was performed on a LightCycler (Roche) instrument
according to the instructions of the LightCycler Fast Start DNA
Masterplus SYBR Green I kit (Roche). The PCR parameters consisted
of an initial denaturation at 94 °C for 5 min, followed by 40 cycles of
94 °C for 10 s, 52 °C for 5 s and 72 °C for 10 s. Subsequentmelting curve
analysis and CT value determination were performed using Roche
LightCycler software version 3.5. Each sample was run in triplicate.
The relative amount of target viral mRNA was normalized to that of
β-actin mRNA in the same sample.
Indirect immunoﬂuorescence assay (IFA)
PK15 monolayer cells seeded in 24-well culture plates were
infected with PCV2 strain BJW. At 72 h, the cells were washed with
phosphate-buffered saline (PBS) and ﬁxed in 4% paraformaldehyde
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ORF2 antibody diluted in 3% bovine serum albumin (BSA)-PBS at
room temperature (RT) for 1 h. After three further washes, cells were
incubated with ﬂuorescein isothiocyanate (FITC)-conjugated anti-
mouse immunoglobulin G (Sigma) at RT for 1 h and washed with PBS
three times. The cells were examined under a ﬂuorescence micro-
scopy and cells positive for PCV2 viral antigens were counted in six
ﬁelds of view.
Whole cell lysates
Whole cell lysate extracts from PK15 cells after infection at various
time points were prepared with the Nuclear Extract kit (Active Motif)
according to the manufacturer's protocol. Protein concentration was
determined by the Bio-Rad protein assay (Bio-Rad, Hercules, CA) with
BSA as a standard.
Western blotting
The whole cell lysate extracts prepared as described above were
diluted in 2× sample buffer and boiled for 5 min. Twenty micrograms
of each extract was resolved on 10% sodium dodecyl sulphate-
polyacrylamide gel electrophoresis (SDS-PAGE) and blotted onto
nitrocellulose (NC) membranes (Stratagene) with a semidry transfer
cell (Bio-Rad Trans-Blot SD). The membranes were blocked for 2 h at
RT in blocking buffer TBST (20 mM Tris–HCl [pH 7.4], 150 mM NaCl,
0.1% Tween-20) containing 5% skim milk powder to prevent
nonspeciﬁc binding, and then incubated with speciﬁc primary
antibodies raised against ORF2, ERK2, phosphorylated (p)-ERK1/2,
and (p)-ElK-1, as well as β-actin at RT for 2 h. The membranes were
washed three times with TBST buffer, and incubated for 2 h at RT
with HRP-conjugated secondary antibodies diluted in blocking buffer
(1:2 000). Immunoreactive bands were visualized by enhanced
chemiluminescence system (Amersham Biosciences).
Statistical analysis
Results are presented as averages±the standard deviations or
standard errors of the means, as indicated. Statistical comparisons are
made by using Student's t test, and differences between groups were
considered signiﬁcant if the P value wasb0.05.
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